Sep 26, 2016 7:00 am EDT Capricor Therapeutics Awarded $2.4 Million from U.S. Department of Defense to Support Manufacturing Process Development for Therapeutic Exosomes
Sep 21, 2016 11:00 am EDT Capricor Therapeutics Announces Closing of Public Offerings Raising Approximately $10.0 Million in Net Proceeds
Sep 07, 2016 6:00 am EDT Capricor Therapeutics Completes Enrollment in Randomized HOPE Clinical Trial in Duchenne Muscular Dystrophy
Sep 01, 2016 7:00 am EDT Capricor Therapeutics to Present at the NewsMakers in the Biotech Industry Conference
Aug 15, 2016 4:05 pm EDT Capricor Therapeutics Reports Second Quarter 2016 Financial Results and Provides Clinical Update
Aug 12, 2016 9:00 am EDT Capricor Therapeutics to Hold Second Quarter 2016 Business Update and Financial Results Conference Call and Webcast on Monday, August 15 at 4:30 p.m. ET
Jun 23, 2016 9:00 am EDT Capricor Therapeutics Provides Enrollment Update on HOPE Clinical Trial in Duchenne Muscular Dystrophy